Raleigh Geriatric Care Management and Alzheimer’s Drug Trials: Joining The Search For The Cure

Many people are afraid to join a clinical drug trial, but participation may be the greatest impact we can have on future generations.
More than 26 million people across the world live with Alzheimer’s disease, and that number is expected to quadruple by 2050. In fact, it is the seventh-leading cause of death in the United States. Alzheimer’s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and may even inhibit the ability to carry out the simplest tasks. Researchers are continuously looking for
new treatments that may impact the course of the disease and ultimately improve the quality of life for people living with the disease.
This year on World Alzheimer’s Day, September 21, patients and caregivers are encouraged to join the fight against Alzheimer’s disease by learning about enrollment in clinical trials that may help researchers learn how to stop or slow the disease from progressing versus simply treating the symptoms.
Today, at least 50,000 volunteers are urgently needed to participate in more than 175 actively enrolling Alzheimer’s disease clinical trials in the U.S. According to the Alzheimer’s Association, research shows that people involved in studies tend to do somewhat better than people in a similar stage of their disease who are not enrolled, regardless of whether the experimental treatment works. Scientists believe this advantage may be due to the general high quality of care provided during clinical studies.
Caregivers may also experience unexpected benefits:
Opportunity to talk regularly to Alzheimer’s experts who have lots of practical experience
Receive valuable advice on the emotional and physical aspects of the disease
Learn about support groups and other helpful resources
One clinical trial that is currently seeking participants is the ICARA Study. The goal of the ICARA Study is to learn if an investigational drug from pharmaceutical maker Elan, bapineuzumab, can help slow the progression of Alzheimer’s. For more information about this trial, visit http://www.icarastudy.com or call 1-888-770-6366.
For more on the importance of taking part in clinical trials, visit the Alzheimer’s Association at http://www.alz.org/alzheimers_disease_clinical_studies.asp
Many people are afraid to join a clinical drug trial, but participation may be the greatest impact we can have on future generations.
More than 26 million people across the world live with Alzheimer’s disease, and that number is expected to quadruple by 2050. In fact, it is the seventh-leading cause of death in the United States. Alzheimer’s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and may even inhibit the ability to carry out the simplest tasks. Researchers are continuously looking for new treatments that may impact the course of the disease and ultimately improve the quality of life for people living with the disease.
This year on World Alzheimer’s Day, September 21, patients and caregivers are encouraged to join the fight against Alzheimer’s disease by learning about enrollment in clinical trials that may help researchers learn how to stop or slow the disease from progressing versus simply treating the symptoms.
Today, at least 50,000 volunteers are urgently needed to participate in more than 175 actively enrolling Alzheimer’s disease clinical trials in the U.S.  Research shows that people involved in studies tend to do somewhat better than people in a similar stage of their disease who are not enrolled, regardless of whether the experimental treatment works. Scientists believe this advantage may be due to the general high quality of care provided during clinical studies.
Caregivers may also experience unexpected benefits:
  • Opportunity to talk regularly to Alzheimer’s experts who have lots of practical experience
  • Receive valuable advice on the emotional and physical aspects of the disease.
  • Learn about support groups and other helpful resources
For more information: lwatral@rgcmgmt.com
Advertisements

Leave a comment

Filed under Alzheimer's Disease, care giving, dementia, elder care raleigh nc, Geriatric Care Management, long term care planning, NC, Raleigh, Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s